News
List of company announcements and press releases.
Click here for announcements regarding managers transactions.
Click here for news in Danish.
April 09, 2025 | Company Announcements
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/SMarch 31, 2025 | Company Announcements
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine March 12, 2025 | Company Announcements
Bavarian Nordic A/S – Notice Convening Annual General Meeting March 07, 2025 | Press Releases
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and OlderMarch 05, 2025 | Company Announcements
Bavarian Nordic Publishes Annual Report 2024February 28, 2025 | Company Announcements
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and OlderFebruary 25, 2025 | Press Releases
Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine February 14, 2025 | Company Announcements
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and OlderFebruary 03, 2025 | Company Announcements
Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025January 31, 2025 | Company Announcements
Bavarian Nordic – Completion of Share Buy-Back ProgramJanuary 31, 2025 | Company Announcements
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and OlderJanuary 27, 2025 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program January 20, 2025 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program January 09, 2025 | Company Announcements
Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million